Natixis Advisors LLC Cuts Stock Position in Colgate-Palmolive (NYSE:CL)

Natixis Advisors LLC lessened its stake in Colgate-Palmolive (NYSE:CL) by 20.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 306,025 shares of the company’s stock after selling 80,656 shares during the quarter. Natixis Advisors LLC’s holdings in Colgate-Palmolive were worth $27,821,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Swedbank AB increased its holdings in Colgate-Palmolive by 1.4% in the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after acquiring an additional 40,324 shares in the last quarter. OneDigital Investment Advisors LLC boosted its stake in Colgate-Palmolive by 23.8% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 14,829 shares of the company’s stock worth $1,539,000 after purchasing an additional 2,847 shares during the last quarter. Thrivent Financial for Lutherans boosted its stake in Colgate-Palmolive by 39.8% during the 3rd quarter. Thrivent Financial for Lutherans now owns 90,023 shares of the company’s stock worth $9,345,000 after purchasing an additional 25,645 shares during the last quarter. Quest Partners LLC boosted its stake in Colgate-Palmolive by 69.6% during the 3rd quarter. Quest Partners LLC now owns 31,829 shares of the company’s stock worth $3,304,000 after purchasing an additional 13,066 shares during the last quarter. Finally, Richard C. Young & CO. LTD. boosted its stake in Colgate-Palmolive by 6.0% during the 3rd quarter. Richard C. Young & CO. LTD. now owns 88,949 shares of the company’s stock worth $9,234,000 after purchasing an additional 5,020 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.0 %

NYSE CL opened at $90.72 on Tuesday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The stock has a market capitalization of $73.62 billion, a P/E ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40. The firm’s 50-day moving average is $89.09 and its two-hundred day moving average is $94.56. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the firm earned $0.87 EPS. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Analyst Upgrades and Downgrades

CL has been the topic of several recent research reports. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, UBS Group lowered their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.